Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ActiPatch vs Etoricoxib in Cervical Osteoarthritis
NCT03542955Completed
- Sponsor
- BioElectronics Corporation
- Start
- May 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in cervical osteoarthritis (2 arms), sponsored by BioElectronics Corporation. Primary endpoint: Neck Disability Index at 4 weeks. Started May 2018; status: completed.
02
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on NCT03542955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542955.